205 related articles for article (PubMed ID: 24485401)
21. Local inhibition of tissue factor reduces the thrombogenicity of disrupted human atherosclerotic plaques: effects of tissue factor pathway inhibitor on plaque thrombogenicity under flow conditions.
Badimon JJ; Lettino M; Toschi V; Fuster V; Berrozpe M; Chesebro JH; Badimon L
Circulation; 1999 Apr; 99(14):1780-7. PubMed ID: 10199872
[TBL] [Abstract][Full Text] [Related]
22. Selective attenuation of the extrinsic limb of the tissue factor-driven coagulation protease cascade by occupancy of a novel peptidyl docking site on tissue factor.
Huang H; Norledge BV; Liu C; Olson AJ; Edgington TS
Biochemistry; 2003 Sep; 42(36):10619-26. PubMed ID: 12962485
[TBL] [Abstract][Full Text] [Related]
23. Selective tissue factor/factor VIIa Inhibitor, ER-410660, and its prodrug, E5539, have anti-venous and anti-arterial thrombotic effects with a low risk of bleeding.
Nagakura T; Tabata K; Kira K; Hirota S; Clark R; Matsuura F; Hiyoshi H
Thromb Res; 2013 Aug; 132(2):271-9. PubMed ID: 23827699
[TBL] [Abstract][Full Text] [Related]
24. Circulating monocytes mirror the imbalance in TF and TFPI expression in carotid atherosclerotic plaques with lipid-rich and calcified morphology.
Basavaraj MG; Sovershaev MA; Egorina EM; Gruber FX; Bogdanov VY; Fallon JT; Østerud B; Mathiesen EB; Hansen JB
Thromb Res; 2012 Apr; 129(4):e134-41. PubMed ID: 22178066
[TBL] [Abstract][Full Text] [Related]
25. Tissue factor, tissue factor pathway inhibitor and vascular endothelial growth factor-A in carotid atherosclerotic plaques.
Migdalski A; Kotschy M; Jawien A
Eur J Vasc Endovasc Surg; 2005 Jul; 30(1):41-7. PubMed ID: 15933981
[TBL] [Abstract][Full Text] [Related]
26. Tissue Factor and Atherothrombosis.
Tatsumi K; Mackman N
J Atheroscler Thromb; 2015; 22(6):543-9. PubMed ID: 26016513
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of tissue factor induced atherothrombosis in apolipoprotein E-/- mice via both enhanced plaque thrombogenicity and plaque instability.
Liu X; Ma J; Ma L; Liu F; Zhang C; Zhang Y; Ni M
J Mol Cell Cardiol; 2019 Feb; 127():1-10. PubMed ID: 30500376
[TBL] [Abstract][Full Text] [Related]
28. Thrombin generation by intimal tissue factor contributes to thrombus formation on macrophage-rich neointima but not normal intima of hyperlipidemic rabbits.
Yamashita A; Matsuda S; Matsumoto T; Moriguchi-Goto S; Takahashi M; Sugita C; Sumi T; Imamura T; Shima M; Kitamura K; Asada Y
Atherosclerosis; 2009 Oct; 206(2):418-26. PubMed ID: 19371874
[TBL] [Abstract][Full Text] [Related]
29. Tissue factor and thrombosis models.
Kretz CA; Vaezzadeh N; Gross PL
Arterioscler Thromb Vasc Biol; 2010 May; 30(5):900-8. PubMed ID: 20393156
[TBL] [Abstract][Full Text] [Related]
30. Role for tissue factor pathway in murine model of vascular remodeling.
Singh R; Pan S; Mueske CS; Witt T; Kleppe LS; Peterson TE; Slobodova A; Chang JY; Caplice NM; Simari RD
Circ Res; 2001 Jul; 89(1):71-6. PubMed ID: 11440980
[TBL] [Abstract][Full Text] [Related]
31. The role of tissue factor pathway inhibitor in atherosclerosis and arterial thrombosis.
Winckers K; ten Cate H; Hackeng TM
Blood Rev; 2013 May; 27(3):119-32. PubMed ID: 23631910
[TBL] [Abstract][Full Text] [Related]
32. Anti-apolipoprotein A-1 auto-antibodies as active modulators of atherothrombosis.
Pagano S; Carbone F; Burger F; Roth A; Bertolotto M; Pane B; Spinella G; Palombo D; Pende A; Dallegri F; Satta N; Virzi J; Fontana P; Mach F; Montecucco F; Vuilleumier N
Thromb Haemost; 2016 Aug; 116(3):554-64. PubMed ID: 27356567
[TBL] [Abstract][Full Text] [Related]
33. Expression of exogenous tissue factor pathway inhibitor in vivo suppresses thrombus formation in injured rabbit carotid arteries.
Golino P; Cirillo P; Calabro' P; Ragni M; D'Andrea D; Avvedimento EV; Vigorito F; Corcione N; Loffredo F; Chiariello M
J Am Coll Cardiol; 2001 Aug; 38(2):569-76. PubMed ID: 11499754
[TBL] [Abstract][Full Text] [Related]
34. Elevated plasma tissue factor levels in neonates with umbilical arterial catheter-associated thrombosis.
Tay SP; Cheong SK; Boo NY
Malays J Pathol; 2006 Jun; 28(1):41-8. PubMed ID: 17694958
[TBL] [Abstract][Full Text] [Related]
35. Endogenous tissue factor pathway inhibitor modulates thrombus formation in an in vivo model of rabbit carotid artery stenosis and endothelial injury.
Ragni M; Golino P; Cirillo P; Scognamiglio A; Piro O; Esposito N; Battaglia C; Botticella F; Ponticelli P; Ramunno L; Chiariello M
Circulation; 2000 Jul; 102(1):113-7. PubMed ID: 10880423
[TBL] [Abstract][Full Text] [Related]
36. Role of tissue factor in atherothrombosis.
Owens AP; Mackman N
Curr Atheroscler Rep; 2012 Oct; 14(5):394-401. PubMed ID: 22886473
[TBL] [Abstract][Full Text] [Related]
37. Increased expression of TFPI in human carotid stenosis.
Stavik B; Holm S; Espada S; Iversen N; Sporsheim B; Bjerkeli V; Dahl TB; Sandset PM; Skjelland M; Espevik T; Skretting G; Halvorsen B
Thromb Res; 2017 Jul; 155():31-37. PubMed ID: 28482260
[TBL] [Abstract][Full Text] [Related]
38. Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischaemic heart disease patients.
Falciani M; Gori AM; Fedi S; Chiarugi L; Simonetti I; Dabizzi RP; Prisco D; Pepe G; Abbate R; Gensini GF; Neri Serneri GG
Thromb Haemost; 1998 Mar; 79(3):495-9. PubMed ID: 9531029
[TBL] [Abstract][Full Text] [Related]
39. Tissue factor and tissue factor pathway inhibitor as key regulators of global hemostasis: measurement of their levels in coagulation assays.
Kasthuri RS; Glover SL; Boles J; Mackman N
Semin Thromb Hemost; 2010 Oct; 36(7):764-71. PubMed ID: 20978997
[TBL] [Abstract][Full Text] [Related]
40. Atherothrombosis and Thromboembolism: Position Paper from the Second Maastricht Consensus Conference on Thrombosis.
Spronk HMH; Padro T; Siland JE; Prochaska JH; Winters J; van der Wal AC; Posthuma JJ; Lowe G; d'Alessandro E; Wenzel P; Coenen DM; Reitsma PH; Ruf W; van Gorp RH; Koenen RR; Vajen T; Alshaikh NA; Wolberg AS; Macrae FL; Asquith N; Heemskerk J; Heinzmann A; Moorlag M; Mackman N; van der Meijden P; Meijers JCM; Heestermans M; Renné T; Dólleman S; Chayouâ W; Ariëns RAS; Baaten CC; Nagy M; Kuliopulos A; Posma JJ; Harrison P; Vries MJ; Crijns HJGM; Dudink EAMP; Buller HR; Henskens YMC; Själander A; Zwaveling S; Erküner O; Eikelboom JW; Gulpen A; Peeters FECM; Douxfils J; Olie RH; Baglin T; Leader A; Schotten U; Scaf B; van Beusekom HMM; Mosnier LO; van der Vorm L; Declerck P; Visser M; Dippel DWJ; Strijbis VJ; Pertiwi K; Ten Cate-Hoek AJ; Ten Cate H
Thromb Haemost; 2018 Feb; 118(2):229-250. PubMed ID: 29378352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
